Skip to main content

Table 1 COX-2 selective inhibitors currently marketed in some European, North American, and Latin American countries

From: COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients

Generic name Proprietary name Manufacturer
celecoxib Celebrex Pharmacia Corporation and Pfizer, Inc
etoricoxib Arcoxia Merck & Co, Inc
rofecoxib Vioxx Merck & Co, Inc
valdecoxib Bextra Pharmacia Corporation and Pfizer, Inc